203 related articles for article (PubMed ID: 2861567)
1. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.
Ortho Multicenter Transplant Study Group
N Engl J Med; 1985 Aug; 313(6):337-42. PubMed ID: 2861567
[TBL] [Abstract][Full Text] [Related]
2. OKT3 prophylaxis versus conventional drug therapy: single-center perspective, part of a multicenter trial.
Kahana L; Narvarte J; Ackermann J; LeFor W; Weinstein S; Wright C; deQuesada A; Baxter J; Shires D
Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):5-9. PubMed ID: 2510510
[TBL] [Abstract][Full Text] [Related]
3. The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.
Norman DJ; Barry JM; Bennett WM; Leone M; Henell K; Funnell B; Hubert B
Am J Kidney Dis; 1988 Feb; 11(2):90-3. PubMed ID: 3124611
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
Norman DJ; Kahana L; Stuart FP; Thistlethwaite JR; Shield CF; Monaco A; Dehlinger J; Wu SC; Van Horn A; Haverty TP
Transplantation; 1993 Jan; 55(1):44-50. PubMed ID: 8420063
[TBL] [Abstract][Full Text] [Related]
5. OKT3 treatment of steroid-resistant renal allograft rejection.
Thistlethwaite JR; Gaber AO; Haag BW; Aronson AJ; Broelsch CE; Stuart JK; Stuart FP
Transplantation; 1987 Feb; 43(2):176-84. PubMed ID: 3544373
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants.
Gordon RD; Starzl TE; Fung JJ; Iwatsuki S; Esquivel CO; Tzakis A; Todo S
Nephron; 1987; 46 Suppl 1(Suppl 1):56-9. PubMed ID: 3306426
[TBL] [Abstract][Full Text] [Related]
8. Anti-rejection therapy in renal transplantation: Use of the monoclonal antibody OKT3.
Nicholson ML; Donnelly PK; Veitch PS; Bell PR
Nephrol Dial Transplant; 1991; 6(4):275-9. PubMed ID: 1881582
[TBL] [Abstract][Full Text] [Related]
9. OKT3: First-dose safety and success.
Cosimi AB
Nephron; 1987; 46 Suppl 1():12-8. PubMed ID: 3306421
[TBL] [Abstract][Full Text] [Related]
10. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin.
Oh CS; Sollinger HW; Stratta RJ; Kalayoglu M; Belzer FO
Transplantation; 1988 Jan; 45(1):65-7. PubMed ID: 3276065
[TBL] [Abstract][Full Text] [Related]
11. Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.
Norman DJ; Shield CF; Barry J; Bennett WM; Henell K; Kimball J; Funnell B; Hubert B
Am J Kidney Dis; 1988 Feb; 11(2):107-10. PubMed ID: 3277400
[TBL] [Abstract][Full Text] [Related]
12. OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.
D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Maki DG; Belzer FO
Transplantation; 1989 Feb; 47(2):297-300. PubMed ID: 2493176
[TBL] [Abstract][Full Text] [Related]
13. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.
Thistlethwaite JR; Stuart JK; Mayes JT; Gaber AO; Stuart FP
Am J Kidney Dis; 1988 Feb; 11(2):94-8. PubMed ID: 3277413
[TBL] [Abstract][Full Text] [Related]
14. [A comparative trial of OKT3 and antilymphocyte serum in the preventive treatment of rejection after kidney transplantation in children].
Niaudet P; Murcia I; Jean G; Broyer M
Ann Pediatr (Paris); 1990 Feb; 37(2):83-5. PubMed ID: 2138866
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejection.
Norman DJ; Shield CF; Barry JM; Henell K; Funnell MB; Lemon J
Nephron; 1987; 46 Suppl 1():41-7. PubMed ID: 3306424
[TBL] [Abstract][Full Text] [Related]
16. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.
Norman DJ; Shield CF; Henell KR; Kimball J; Barry JM; Bennett WM; Leone M
Transplantation; 1988 Oct; 46(4):523-9. PubMed ID: 3140448
[TBL] [Abstract][Full Text] [Related]
18. A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.
Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Hudson S; Barger BO; Diethelm AG
Am J Kidney Dis; 1988 Feb; 11(2):86-9. PubMed ID: 3277412
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.
Cosimi AB; Burton RC; Colvin RB; Goldstein G; Delmonico FL; LaQuaglia MP; Tolkoff-Rubin N; Rubin RH; Herrin JT; Russell PS
Transplantation; 1981 Dec; 32(6):535-9. PubMed ID: 7041358
[TBL] [Abstract][Full Text] [Related]
20. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
Ascher NL; Stock PG; Bumgardner GL; Payne WD; Najarian JS
Surg Gynecol Obstet; 1988 Dec; 167(6):474-84. PubMed ID: 3055368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
